Medicared For All Logo

Mark Wieland MD in San Jose, California

Home California San Jose

Mark Wieland MD has Ophthalmology as his primary medical specialty. Their primary office is: 2512 Samaritan Ct P in San Jose, California.

They're a part of the: Northern California Retina Vitreous Associates Medical Group, Inc. medical group which has around 7 members. You can call their office at 408-356-8818 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University and graduated in 1985 (around 39 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark R Wieland MD Office Phone and Directions

Mark Wieland MD
Northern California Retina Vitreous Associates Medical Group, Inc.
2512 Samaritan Ct P
San Jose, California 95124
408-356-8818


Patient Ratings
Please rate your experience with Mark Wieland MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 408-356-8818


Enter a starting address:


Healthcare Info for Mark Wieland MD

Medical School: Clvlnd Clinic Lerner College Of Med Of Case Wstn Rsv University
Graduation Year: 1985
The Primary Medical Specialty for Mark Wieland MD is listed as: Ophthalmology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 6608830625
NPI #: 1134114382
NPI Created On: 09/14/2005
NPI Last Updated Listed as: 12/14/2017
Primary Taxonomy Code: 207W00000X
License Number:
00A48482
Listed Gender: Male

Procedures, Services, Charges


Services and Procedures include:

  1. Injection of drug into eye
  2. Laser destruction of leaking retinal blood vessels, 1 or more sessions
  3. Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits
  4. Eye and medical examination for diagnosis and treatment, established patient
  5. Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
  6. Diagnostic imaging of optic nerve of eye
  7. Diagnostic imaging of retina
  8. Extended examination of eye with drawing of retina
  9. Imaging of blood vessels in back of eye using fluorescein dye
  10. Photography of the retina
  11. New patient office or other outpatient visit, typically 45 minutes
  12. Injection, aflibercept, 1 mg
  13. Injection, ranibizumab, 0.1 mg
  14. Compounded drug, not otherwise classified

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799200211

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Chronic Non-infectious Posterior Segment Uveitis

Name of Drug #1: YUTIQ

Open Associated Drug #1: 71879-136-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 799202327

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Chronic Non-infectious Posterior Segment Uveitis

Name of Drug #1: YUTIQ

Open Associated Drug #1: 71879-136-01


Payments Total: $4,710

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946663

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946645

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology and Ophthalmology

Name of Drug #1: SUSVIMO

Open Associated Drug #1: 50242-078-12


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946647

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Immunology and Ophthalmology

Name of Drug #1: SUSVIMO

Open Associated Drug #1: 50242-078-12


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946655

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946657

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $136

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835946659

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809636095

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Ophthalmology Professionals in San Jose

200 Jose Figueres Ave
San-jose, CA
Northern California Retina Vitreous Associates Medical Group, Inc.

2107 N 1st St
San-jose, CA
Furlong Vision Correction Medical Center Inc

200 Jose Figueres Ave
San-jose, CA
Retinal Diagnostic Center A Medical Corporation

2110 Forest Ave
San-jose, CA
Carey Vision Medical Group Inc

220 Meridian Ave
San-jose, CA
Bdhv Medical Group Of California Pc

220 Meridian Ave
San-jose, CA
Bdhv Medical Group Of California Pc

Providers in Northern California Retina Vitreous Associates Medical Group, Inc.

1.Alok Bansal

2485 Hospital Dr
Mountain View Ca 94040-4123
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

2.Alok Bansal

50 S San Mateo Dr
San Mateo Ca 94401-3859
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

3.Alok Bansal

2512 Samaritan Ct P
San Jose Ca 95124-4002
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

4.Jesus Borrillo Md

2485 Hospital Dr
Mountain View Ca 94040-4123
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

5.Jesus Borrillo Md

50 S San Mateo Dr
San Mateo Ca 94401-3859
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

6.Jesus Borrillo Md

2512 Samaritan Ct P
San Jose Ca 95124-4002
Northern California Retina Vitreous Associates Medical Group, Inc.
Ophthalmology

View all 7 members of Northern California Retina Vitreous Associates Medical Group, Inc. medical group